Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD

ClinicalTrials.gov ID: NCT00228540

Public ClinicalTrials.gov record NCT00228540. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 16, 2026, 8:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

An 8-week, Open-Label Study to Characterize the Response to Modafinil (85mg Film-Coated Tablet) Treatment at Dosages up to 425mg/Day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period)

Study identification

NCT ID
NCT00228540
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2005 (Type not available)
Primary completion
Not listed
Completion
Sep 2006 (Actual)
Last update posted
May 9, 2014

2005 – 2006

United States locations

U.S. sites
39
U.S. states
22
U.S. cities
38
Facility City State ZIP Site status
Melmed Center Scottsdale Arizona 85254 —
UCI Child Development Center Irvine California 92612 —
Pharmacology Research Institut Northridge California 91324 —
Pacific Sleep Medicine Service San Diego California 92121 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Clinical Neuroscience Solution Jacksonville Florida 32216 —
Clinical Neurosciences Orlando Florida 32806 —
Laszlo J. Mate, MD, PA West Palm Beach Florida 33407 —
Northwest Behavioral Research Marietta Georgia 30060 —
Pediatrics and Adolescent Woodstock Georgia 30189 —
Loyola University Medical Center Department of Psychiatry Maywood Illinois 60153 —
HALP Clinic and ADHD Research Northbrook Illinois 60062 —
Cientifica, Inc. Wichita Kansas 67207 —
Michael J. Rieser, MD Lexington Kentucky 40509 —
Pedia Research, LLC Owensboro Kentucky 42301 —
Louisiana Research Associates New Orleans Louisiana 70114 —
Psycopharmacology Research - LSU Health Science Center Shreveport Louisiana 71103 —
Massachusetts General Hospital Cambridge Massachusetts 02138 —
Odyssey Research Dearborn Michigan 48126 —
Hurley Medical Center Flint Michigan 48503 —
ProMed HealthCare Kalamazoo Michigan 49008 —
Regions Hospital Saint Paul Minnesota 55101 —
Odyssey Research McCook Nebraska 69001 —
University of Nebraska Omaha Nebraska 68198-7630 —
Bancroft Clinical Research Cherry Hill New Jersey 08034 —
Hunterdon Pediatric Associates Flemington New Jersey 08822 —
Odyssey Research Bismarck North Dakota 58501 —
Prairie at Saint John's Fargo North Dakota 58104 —
Odyssey Research Minot North Dakota 58701 —
Cincinnati Children's Hospital Cincinnati Ohio 45229 —
OCCI, Inc Salem Salem Oregon 97301 —
Medical University of SC Charleston South Carolina 29425 —
UT Medical Group Memphis Tennessee 38105 —
Clinical Neuroscience Solution Memphis Tennessee 38119 —
Claghorn-Lesem Research Bellaire Texas 77401 —
The Clinical Study Ceneter Burlington Vermont 05401 —
Dominion Clinical Research Midlothian Virginia 23112 —
Advanced Pediatrics Vienna Virginia 22180 —
Eastside Therapeutic Resource Kirkland Washington 98033 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00228540, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 9, 2014 · Synced Oct 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00228540 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →